Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.53 USD
−12.59 M USD
0.00 USD
About Genenta Science S.p.A.
Sector
CEO
Pierluigi Paracchi
Headquarters
Milan
Website
Founded
2014
FIGI
BBG013GNLJL6
Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. Its lead product candidate, Temferon, was developed using its platform and carries an interferon-alpha payload. The company was founded by Pierluigi Paracchi, Luigi Naldini and Bernhard Gentner on July 24, 2014 and is headquartered in Milan, Italy.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.